Literature DB >> 21338336

Dose response in rodents and nonhuman primates after hydrodynamic limb vein delivery of naked plasmid DNA.

Christine I Wooddell1, Julia O Hegge, Guofeng Zhang, Magdolna G Sebestyén, Mark Noble, Jacob B Griffin, Loretta V Pfannes, Hans Herweijer, James E Hagstrom, Serge Braun, Thierry Huss, Jon A Wolff.   

Abstract

The efficacy of gene therapy mediated by plasmid DNA (pDNA) depends on the selection of suitable vectors and doses. Using hydrodynamic limb vein (HLV) injection to deliver naked pDNA to skeletal muscles of the limbs, we evaluated key parameters that affect expression in muscle from genes encoded in pDNA. Short-term and long-term promoter comparisons demonstrated that kinetics of expression differed between cytomegalovirus (CMV), muscle creatine kinase, and desmin promoters, but all gave stable expression from 2 to 49 weeks after delivery to mouse muscle. Expression from the CMV promoter was highest. For mice, rats, and rhesus monkeys, the linear range for pDNA dose response could be defined by the mass of pDNA relative to the mass of target muscle. Correlation between pDNA dose and expression was linear between a threshold dose of 75 μg/g and maximal expression at approximately 400 μg/g. One HLV injection into rats of a dose of CMV-LacZ yielding maximal expression resulted in an average transfection of 28% of all hind leg muscle and 40% of the gastrocnemius and soleus. Despite an immune reaction to the reporter gene in monkeys, a single injection transfected an average of 10% of all myofibers in the targeted muscle of the arms and legs and an average of 15% of myofibers in the gastrocnemius and soleus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21338336      PMCID: PMC3135275          DOI: 10.1089/hum.2010.160

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  35 in total

1.  Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers.

Authors:  T P Le; K M Coonan; R C Hedstrom; Y Charoenvit; M Sedegah; J E Epstein; S Kumar; R Wang; D L Doolan; J D Maguire; S E Parker; P Hobart; J Norman; S L Hoffman
Journal:  Vaccine       Date:  2000-03-17       Impact factor: 3.641

Review 2.  Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse.

Authors:  J M Gillis
Journal:  J Muscle Res Cell Motil       Date:  1999-10       Impact factor: 2.698

3.  Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro.

Authors:  C H Miao; K Ohashi; G A Patijn; L Meuse; X Ye; A R Thompson; M A Kay
Journal:  Mol Ther       Date:  2000-06       Impact factor: 11.454

4.  Slow accumulation of plasmid in muscle cells: supporting evidence for a mechanism of DNA uptake by receptor-mediated endocytosis.

Authors:  S Satkauskas; M F Bureau; A Mahfoudi; L M Mir
Journal:  Mol Ther       Date:  2001-10       Impact factor: 11.454

5.  A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs.

Authors:  James E Hagstrom; Julia Hegge; Guofeng Zhang; Mark Noble; Vladimir Budker; David L Lewis; Hans Herweijer; Jon A Wolff
Journal:  Mol Ther       Date:  2004-08       Impact factor: 11.454

6.  Time course of gene expression after plasmid DNA gene transfer to the liver.

Authors:  H Herweijer; G Zhang; V M Subbotin; V Budker; P Williams; J A Wolff
Journal:  J Gene Med       Date:  2001 May-Jun       Impact factor: 4.565

7.  Efficient expression of naked dna delivered intraarterially to limb muscles of nonhuman primates.

Authors:  G Zhang; V Budker; P Williams; V Subbotin; J A Wolff
Journal:  Hum Gene Ther       Date:  2001-03-01       Impact factor: 5.695

8.  Intraarterial delivery of naked plasmid DNA expressing full-length mouse dystrophin in the mdx mouse model of duchenne muscular dystrophy.

Authors:  Goufeng Zhang; James J Ludtke; Christine Thioudellet; Patricia Kleinpeter; Michael Antoniou; Hans Herweijer; Serge Braun; Jon A Wolff
Journal:  Hum Gene Ther       Date:  2004-08       Impact factor: 5.695

9.  Autosomal recessive distal muscular dystrophy as a new type of progressive muscular dystrophy. Seventeen cases in eight families including an autopsied case.

Authors:  K Miyoshi; H Kawai; M Iwasa; K Kusaka; H Nishino
Journal:  Brain       Date:  1986-02       Impact factor: 13.501

10.  A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells.

Authors:  H Okayama; P Berg
Journal:  Mol Cell Biol       Date:  1983-02       Impact factor: 4.272

View more
  9 in total

Review 1.  Gene and cell-mediated therapies for muscular dystrophy.

Authors:  Patryk Konieczny; Kristy Swiderski; Jeffrey S Chamberlain
Journal:  Muscle Nerve       Date:  2013-03-29       Impact factor: 3.217

Review 2.  Genome engineering: a new approach to gene therapy for neuromuscular disorders.

Authors:  Christopher E Nelson; Jacqueline N Robinson-Hamm; Charles A Gersbach
Journal:  Nat Rev Neurol       Date:  2017-09-29       Impact factor: 42.937

Review 3.  Translational Advances of Hydrofection by Hydrodynamic Injection.

Authors:  Luis Sendra; María José Herrero; Salvador F Aliño
Journal:  Genes (Basel)       Date:  2018-03-01       Impact factor: 4.096

4.  Induction of a local muscular dystrophy using electroporation in vivo: an easy tool for screening therapeutics.

Authors:  Aline Derenne; Alexandra Tassin; Thuy Hang Nguyen; Estelle De Roeck; Vincianne Jenart; Eugénie Ansseau; Alexandra Belayew; Frédérique Coppée; Anne-Emilie Declèves; Alexandre Legrand
Journal:  Sci Rep       Date:  2020-07-09       Impact factor: 4.379

5.  Measuring microRNA reporter activity in skeletal muscle using hydrodynamic limb vein injection of plasmid DNA combined with in vivo imaging.

Authors:  Martin G Guess; Kristen Kb Barthel; Emily K Pugach; Leslie A Leinwand
Journal:  Skelet Muscle       Date:  2013-08-01       Impact factor: 4.912

6.  Development and utility of an internal threshold control (ITC) real-time PCR assay for exogenous DNA detection.

Authors:  Weiyi Ni; Caroline Le Guiner; Philippe Moullier; Richard O Snyder
Journal:  PLoS One       Date:  2012-05-03       Impact factor: 3.240

7.  Condensation of plasmid DNA enhances mitochondrial association in skeletal muscle following hydrodynamic limb vein injection.

Authors:  Yukari Yasuzaki; Yuma Yamada; Yutaka Fukuda; Hideyoshi Harashima
Journal:  Pharmaceuticals (Basel)       Date:  2014-08-21

8.  DNA-Mediated Gene Therapy in a Mouse Model of Limb Girdle Muscular Dystrophy 2B.

Authors:  Julia Ma; Christophe Pichavant; Haley du Bois; Mital Bhakta; Michele P Calos
Journal:  Mol Ther Methods Clin Dev       Date:  2017-10-24       Impact factor: 6.698

9.  Plasmid-Mediated Gene Therapy in Mouse Models of Limb Girdle Muscular Dystrophy.

Authors:  Tuhin K Guha; Christophe Pichavant; Michele P Calos
Journal:  Mol Ther Methods Clin Dev       Date:  2019-10-14       Impact factor: 6.698

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.